Wlds mice are resistant to paclitaxel (Taxol) neuropathy

Annals of Neurology

Volumn 52, Issue 4, 2002, Pages 442-447

  Wang, Min Sheng ^a   Davis, Albert A ^a   Culver, Deborah G ^a   Glass, Jonathan D ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; ANTINEOPLASTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG INDUCED DISEASE; MOUSE; MOUSE MUTANT; MOUSE STRAIN; NERVE DEGENERATION; NERVE FIBER DEGENERATION; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PERIPHERAL NEUROPATHY; PHENOTYPE; PRIORITY JOURNAL; SENSORY NEUROPATHY; STRAIN DIFFERENCE; WILD TYPE; ANIMAL; C57BL MOUSE; CELL CULTURE; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DRUG EFFECT; FEMALE; GENETIC PREDISPOSITION; GENETICS; NERVE FIBER; PATHOLOGY; SENSORY NERVE CELL; SPINAL GANGLION; ULTRASTRUCTURE;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; AXONS; CELLS, CULTURED; FEMALE; GANGLIA, SPINAL; GENETIC PREDISPOSITION TO DISEASE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; NEURONS, AFFERENT; PACLITAXEL; PERIPHERAL NERVOUS SYSTEM DISEASES; PHENOTYPE; WALLERIAN DEGENERATION;

EID: 0036771836     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10300     Document Type: Article

References (14)

1. Coleman MP, Conforti L, Buckmaster EA, et al. An 85-kb tandem triplication in the slow Wallerian degeneration (Wlds) mouse. Proc Natl Acad Sci USA 1998;95:9985-9990.
2. s) mouse. Proc Natl Acad Sci USA 2000;97:11377-11382.
3. Mack TG, Reiner M, Beirowski B, et al. Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. Nat Neurosci 2001;4:12.
4. Wang MS, Wu Y, Culver DG, Glass JD. The gene for slow Wallerian degeneration (Wld(s)) is also protective against vincristine neuropathy. Neurobiol Dis 2001;8:155-161.
5. Wang MS, Fang G, Culver DG, et al. The WldS protein protects against axonal degeneration: a model of gene therapy for peripheral neuropathy. Ann Neurol 2001;50:773-779.
6. Mimura Y, Kato H, Eguchi K, Ogawa T. Schedule dependency of paclitaxel-induced neuropathy in mice: a morphological study. Neurotoxicology 2000;21:513-520.
7. Lipton RB, Apfel SC, Dutcher JP, et al. Taxol produces a predominantly sensory neuropathy. Neurology 1989;39:368-373.
8. Wang MS, Wu Y, Culver DG, Glass JD. Pathogenesis of axonal degeneration: parallels between Wallerian degeneration and vincristine neuropathy. J Neuropathol Exp Neurol 2000; 59:599-606.
9. Blagosklonny MV, Schulte T, Nguyen P, et al. Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway. Cancer Res 1996;56:1851-1854.
10. Cavaletti G, Tredici G, Braga M, Tazzari S. Experimental peripheral neuropathy induced in adult rats by repeated intraperitoneal administration of taxol. Exp Neurol 1995;133:64-72.
11. Chaudhry V, Rowinsky EK, Sartorius SE, et al. Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies. Ann Neurol 1994;35: 304-311.
12. Sahenk Z, Barohn R, New P, Mendell JR. Taxol neuropathy: electrodiagnostic and sural nerve biopsy findings. Arch Neurol 1994;51:726-729.
13. Theiss C, Meller K. Taxol impairs anterograde axonal transport of microinjected horseradish peroxidase in dorsal root ganglia neurons in vitro. Cell Tissue Res 2000;299:213-224.
14. Nakata T, Yorifuji H. Morphological evidence of the inhibitory effect of taxol on the fast axonal transport. Neurosci Res 1999; 35:113-122.